Report Detail
Global (United States, European Union and China) Nuclear Receptor ROR-Gamma Market Research Report 2019-2025
- RnM3364067 |
- 13 July, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Pharma & Healthcare
Nuclear Receptor ROR-Gamma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Receptor ROR-Gamma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nuclear Receptor ROR-Gamma market is segmented into
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
Segment by Application, the Nuclear Receptor ROR-Gamma market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Nuclear Receptor ROR-Gamma market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Receptor ROR-Gamma market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Receptor ROR-Gamma Market Share Analysis
Nuclear Receptor ROR-Gamma market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nuclear Receptor ROR-Gamma business, the date to enter into the Nuclear Receptor ROR-Gamma market, Nuclear Receptor ROR-Gamma product introduction, recent developments, etc.
The major vendors covered:
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.
1 Study Coverage
- 1.1 Nuclear Receptor ROR-Gamma Product Introduction
- 1.2 Market Segments
- 1.3 Key Nuclear Receptor ROR-Gamma Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type
- 1.4.2 VPR-66
- 1.4.3 INV-17
- 1.4.4 GSK-2981278
- 1.4.5 BBI-6000
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Receptor ROR-Gamma Market Size, Estimates and Forecasts
- 2.1.1 Global Nuclear Receptor ROR-Gamma Revenue 2015-2026
- 2.1.2 Global Nuclear Receptor ROR-Gamma Sales 2015-2026
- 2.2 Global Nuclear Receptor ROR-Gamma, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Nuclear Receptor ROR-Gamma Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Nuclear Receptor ROR-Gamma Competitor Landscape by Players
- 3.1 Nuclear Receptor ROR-Gamma Sales by Manufacturers
- 3.1.1 Nuclear Receptor ROR-Gamma Sales by Manufacturers (2015-2020)
- 3.1.2 Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturers (2015-2020)
- 3.2 Nuclear Receptor ROR-Gamma Revenue by Manufacturers
- 3.2.1 Nuclear Receptor ROR-Gamma Revenue by Manufacturers (2015-2020)
- 3.2.2 Nuclear Receptor ROR-Gamma Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2019
- 3.2.5 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Nuclear Receptor ROR-Gamma Price by Manufacturers
- 3.4 Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Receptor ROR-Gamma Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Receptor ROR-Gamma Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Receptor ROR-Gamma Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Nuclear Receptor ROR-Gamma Market Size by Type (2015-2020)
- 4.1.1 Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020)
- 4.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020)
- 4.1.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Nuclear Receptor ROR-Gamma Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2026)
- 4.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Type (2021-2026)
- 4.2.3 Nuclear Receptor ROR-Gamma Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Nuclear Receptor ROR-Gamma Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Nuclear Receptor ROR-Gamma Market Size by Application (2015-2020)
- 5.1.1 Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020)
- 5.1.2 Global Nuclear Receptor ROR-Gamma Revenue by Application (2015-2020)
- 5.1.3 Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
- 5.2 Nuclear Receptor ROR-Gamma Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2026)
- 5.2.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Nuclear Receptor ROR-Gamma Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Nuclear Receptor ROR-Gamma by Country
- 6.1.1 North America Nuclear Receptor ROR-Gamma Sales by Country
- 6.1.2 North America Nuclear Receptor ROR-Gamma Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Nuclear Receptor ROR-Gamma Market Facts & Figures by Type
- 6.3 North America Nuclear Receptor ROR-Gamma Market Facts & Figures by Application
7 Europe
- 7.1 Europe Nuclear Receptor ROR-Gamma by Country
- 7.1.1 Europe Nuclear Receptor ROR-Gamma Sales by Country
- 7.1.2 Europe Nuclear Receptor ROR-Gamma Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Nuclear Receptor ROR-Gamma Market Facts & Figures by Type
- 7.3 Europe Nuclear Receptor ROR-Gamma Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Nuclear Receptor ROR-Gamma by Region
- 8.1.1 Asia Pacific Nuclear Receptor ROR-Gamma Sales by Region
- 8.1.2 Asia Pacific Nuclear Receptor ROR-Gamma Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Nuclear Receptor ROR-Gamma Market Facts & Figures by Type
- 8.3 Asia Pacific Nuclear Receptor ROR-Gamma Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Nuclear Receptor ROR-Gamma by Country
- 9.1.1 Latin America Nuclear Receptor ROR-Gamma Sales by Country
- 9.1.2 Latin America Nuclear Receptor ROR-Gamma Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Nuclear Receptor ROR-Gamma Market Facts & Figures by Type
- 9.3 Central & South America Nuclear Receptor ROR-Gamma Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Nuclear Receptor ROR-Gamma by Country
- 10.1.1 Middle East and Africa Nuclear Receptor ROR-Gamma Sales by Country
- 10.1.2 Middle East and Africa Nuclear Receptor ROR-Gamma Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Nuclear Receptor ROR-Gamma Market Facts & Figures by Type
- 10.3 Middle East and Africa Nuclear Receptor ROR-Gamma Market Facts & Figures by Application
11 Company Profiles
- 11.1 4SC AG
- 11.1.1 4SC AG Corporation Information
- 11.1.2 4SC AG Description and Business Overview
- 11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered
- 11.1.5 4SC AG Related Developments
- 11.2 Advinus Therapeutics Ltd.
- 11.2.1 Advinus Therapeutics Ltd. Corporation Information
- 11.2.2 Advinus Therapeutics Ltd. Description and Business Overview
- 11.2.3 Advinus Therapeutics Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Products Offered
- 11.2.5 Advinus Therapeutics Ltd. Related Developments
- 11.3 Arrien Pharmaceuticals, LLC
- 11.3.1 Arrien Pharmaceuticals, LLC Corporation Information
- 11.3.2 Arrien Pharmaceuticals, LLC Description and Business Overview
- 11.3.3 Arrien Pharmaceuticals, LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Products Offered
- 11.3.5 Arrien Pharmaceuticals, LLC Related Developments
- 11.4 Aurigene Discovery Technologies Limited
- 11.4.1 Aurigene Discovery Technologies Limited Corporation Information
- 11.4.2 Aurigene Discovery Technologies Limited Description and Business Overview
- 11.4.3 Aurigene Discovery Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Products Offered
- 11.4.5 Aurigene Discovery Technologies Limited Related Developments
- 11.5 Biogen, Inc.
- 11.5.1 Biogen, Inc. Corporation Information
- 11.5.2 Biogen, Inc. Description and Business Overview
- 11.5.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Products Offered
- 11.5.5 Biogen, Inc. Related Developments
- 11.6 Brickell Biotech, Inc.
- 11.6.1 Brickell Biotech, Inc. Corporation Information
- 11.6.2 Brickell Biotech, Inc. Description and Business Overview
- 11.6.3 Brickell Biotech, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Products Offered
- 11.6.5 Brickell Biotech, Inc. Related Developments
- 11.7 Bristol-Myers Squibb Company
- 11.7.1 Bristol-Myers Squibb Company Corporation Information
- 11.7.2 Bristol-Myers Squibb Company Description and Business Overview
- 11.7.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Products Offered
- 11.7.5 Bristol-Myers Squibb Company Related Developments
- 11.8 Celgene Corporation
- 11.8.1 Celgene Corporation Corporation Information
- 11.8.2 Celgene Corporation Description and Business Overview
- 11.8.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Celgene Corporation Nuclear Receptor ROR-Gamma Products Offered
- 11.8.5 Celgene Corporation Related Developments
- 11.9 Genentech, Inc.
- 11.9.1 Genentech, Inc. Corporation Information
- 11.9.2 Genentech, Inc. Description and Business Overview
- 11.9.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Products Offered
- 11.9.5 Genentech, Inc. Related Developments
- 11.10 Genfit SA
- 11.10.1 Genfit SA Corporation Information
- 11.10.2 Genfit SA Description and Business Overview
- 11.10.3 Genfit SA Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Genfit SA Nuclear Receptor ROR-Gamma Products Offered
- 11.10.5 Genfit SA Related Developments
- 11.1 4SC AG
- 11.1.1 4SC AG Corporation Information
- 11.1.2 4SC AG Description and Business Overview
- 11.1.3 4SC AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 4SC AG Nuclear Receptor ROR-Gamma Products Offered
- 11.1.5 4SC AG Related Developments
- 11.12 Hanmi Pharmaceuticals, Co. Ltd.
- 11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
- 11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Description and Business Overview
- 11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Products Offered
- 11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Related Developments
- 11.13 Karo Bio AB
- 11.13.1 Karo Bio AB Corporation Information
- 11.13.2 Karo Bio AB Description and Business Overview
- 11.13.3 Karo Bio AB Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Karo Bio AB Products Offered
- 11.13.5 Karo Bio AB Related Developments
- 11.14 Lead Pharma Holding B.V.
- 11.14.1 Lead Pharma Holding B.V. Corporation Information
- 11.14.2 Lead Pharma Holding B.V. Description and Business Overview
- 11.14.3 Lead Pharma Holding B.V. Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Lead Pharma Holding B.V. Products Offered
- 11.14.5 Lead Pharma Holding B.V. Related Developments
- 11.15 Nuevolution AB
- 11.15.1 Nuevolution AB Corporation Information
- 11.15.2 Nuevolution AB Description and Business Overview
- 11.15.3 Nuevolution AB Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Nuevolution AB Products Offered
- 11.15.5 Nuevolution AB Related Developments
- 11.16 Phenex Pharmaceuticals AG
- 11.16.1 Phenex Pharmaceuticals AG Corporation Information
- 11.16.2 Phenex Pharmaceuticals AG Description and Business Overview
- 11.16.3 Phenex Pharmaceuticals AG Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Phenex Pharmaceuticals AG Products Offered
- 11.16.5 Phenex Pharmaceuticals AG Related Developments
- 11.17 Reata Pharmaceuticals, Inc.
- 11.17.1 Reata Pharmaceuticals, Inc. Corporation Information
- 11.17.2 Reata Pharmaceuticals, Inc. Description and Business Overview
- 11.17.3 Reata Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Reata Pharmaceuticals, Inc. Products Offered
- 11.17.5 Reata Pharmaceuticals, Inc. Related Developments
- 11.18 Teijin Pharma Limited
- 11.18.1 Teijin Pharma Limited Corporation Information
- 11.18.2 Teijin Pharma Limited Description and Business Overview
- 11.18.3 Teijin Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Teijin Pharma Limited Products Offered
- 11.18.5 Teijin Pharma Limited Related Developments
- 11.19 Visionary Pharmaceuticals, Inc.
- 11.19.1 Visionary Pharmaceuticals, Inc. Corporation Information
- 11.19.2 Visionary Pharmaceuticals, Inc. Description and Business Overview
- 11.19.3 Visionary Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Visionary Pharmaceuticals, Inc. Products Offered
- 11.19.5 Visionary Pharmaceuticals, Inc. Related Developments
- 11.20 Vitae Pharmaceuticals, Inc.
- 11.20.1 Vitae Pharmaceuticals, Inc. Corporation Information
- 11.20.2 Vitae Pharmaceuticals, Inc. Description and Business Overview
- 11.20.3 Vitae Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Vitae Pharmaceuticals, Inc. Products Offered
- 11.20.5 Vitae Pharmaceuticals, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Nuclear Receptor ROR-Gamma Market Estimates and Projections by Region
- 12.1.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Regions 2021-2026
- 12.1.2 Global Nuclear Receptor ROR-Gamma Revenue Forecast by Regions 2021-2026
- 12.2 North America Nuclear Receptor ROR-Gamma Market Size Forecast (2021-2026)
- 12.2.1 North America: Nuclear Receptor ROR-Gamma Sales Forecast (2021-2026)
- 12.2.2 North America: Nuclear Receptor ROR-Gamma Revenue Forecast (2021-2026)
- 12.2.3 North America: Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2021-2026)
- 12.3 Europe Nuclear Receptor ROR-Gamma Market Size Forecast (2021-2026)
- 12.3.1 Europe: Nuclear Receptor ROR-Gamma Sales Forecast (2021-2026)
- 12.3.2 Europe: Nuclear Receptor ROR-Gamma Revenue Forecast (2021-2026)
- 12.3.3 Europe: Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Nuclear Receptor ROR-Gamma Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Nuclear Receptor ROR-Gamma Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Nuclear Receptor ROR-Gamma Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Nuclear Receptor ROR-Gamma Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Nuclear Receptor ROR-Gamma Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Nuclear Receptor ROR-Gamma Sales Forecast (2021-2026)
- 12.5.2 Latin America: Nuclear Receptor ROR-Gamma Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Nuclear Receptor ROR-Gamma Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Nuclear Receptor ROR-Gamma Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Nuclear Receptor ROR-Gamma Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Nuclear Receptor ROR-Gamma Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Nuclear Receptor ROR-Gamma Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Receptor ROR-Gamma Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Receptor ROR-Gamma. Industry analysis & Market Report on Nuclear Receptor ROR-Gamma is a syndicated market report, published as Global (United States, European Union and China) Nuclear Receptor ROR-Gamma Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nuclear Receptor ROR-Gamma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
